RSS Feed
February 28th, 2012 
FAKE NEWS for the Zionist agenda MONDAY, Feb. 27 (HealthDay News) — The American Academy of
Pediatrics on Monday renewed its call that all boys ages 11 and 12 receive
the three-dose vaccine for the human papillomavirus (HPV).
The HPV vaccine has been available and recommended for girls and young
women since 2006, because it’s highly effective at preventing cervical
cancer. Since then, other cancers thought to be caused by HPV have
increased, including anal cancer and some head and neck cancers.
“Initially, when HPV vaccines were being evaluated, there was an
assumption that they would be for preventing cervical cancer and genital
warts. Subsequent to that, some things have occurred that show us that
providing the vaccine to both genders would be beneficial,” Dr. Michael
Brady, chairman of the academy’s Committee on Infectious Diseases, told
HealthDay.
“Currently, our approach isn’t effective from a public health
perspective since males are also participants in the transmission of HPV.
If we include both girls and boys, we could have a potential impact on HPV
transmission,” added Brady, also physician-in-chief at Nationwide
Children’s Hospital in Columbus, Ohio.
The new guidelines, published online Feb. 27 in the journal
Pediatrics, mirror a recommendation released last October by the
U.S. Centers for Disease Control and Prevention’s Advisory Committee on
Immunization Practices.
The HPV virus can cause cervical, anal and some head and neck cancers,
as well as genital warts, according to the CDC. The virus is transmitted
though genital or oral sex, and many people who have the virus don’t know
they have it. To be effective, the vaccine for the virus must be given
before someone is ever infected. That’s why health experts recommend
giving it in the preteen years of 11 or 12.
“I understand most parents aren’t interested in hearing about their
children being sexually active, but this is a cancer vaccine that’s given
for a number of different reasons that has to be given prior to the onset
of sexual activity,” Brady said, adding that another reason to give the
vaccine at a younger age is that studies have shown the immune system
responds more strongly to the vaccine at this age. “Children between 9 and
12 get the best response to this vaccine,” he explained.
He cautioned that the vaccine doesn’t protect against all sexually
transmitted diseases. Whether vaccinated against HPV or not, practicing
safe sex is still crucial for preventing potentially life-threatening
infections.
“Plus, if you give HPV vaccine only to females, you won’t have any
impact for men who have sex with men. By expanding the vaccine to both
genders, we would reduce the overall transmission of HPV. And, we would
make sure all of the complications of HPV would be prevented in both
genders,” said Brady.
Brady noted that this vaccine is quite safe, with the most significant
side effect being transient soreness in the vaccinated arm. “This vaccine
has very minimal risk,” he said. However, he said any time you give
children in this age group a vaccination or take their blood, they are
more likely to faint than people in other age groups. For this reason,
your child will be asked to sit for 15 minutes or so after getting the
vaccine to make sure that doesn’t happen.
One vaccine expert agreed with the new recommendation.
“What the AAP is doing is being consistent with the [CDC]
recommendations. There will be a benefit to women from immunizing men, as
well as the prevention of warts in males, and possibly cancer associated
with HPV,” said Dr. Kenneth Bromberg, director of the Vaccine Research
Center at the Brooklyn Hospital Center in New York City.
Both experts said that by providing the vaccine to girls and boys, the
vaccine might become less controversial. And, because the CDC recommends
it, both said that insurance coverage likely wouldn’t be an issue. The
three-shot regimen costs approximately $360.
More information
Learn more about HPV vaccine from the U.S. Centers for
Disease Control and Prevention.
Related posts:
Views: 0
Posted in 
Tags: 
